Hematology/Oncology — Medicare Part B billing by state
288 physician groups whose primary specialty is Hematology/Oncology billed $2.6B to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Florida | $442.6M | $444.1M | 38 | $11.7M | 34.1M | 1.9M | 897K |
| Texas | $368.4M | $363.3M | 32 | $11.4M | 24.9M | 1.5M | 779K |
| New York | $169.5M | $179.0M | 26 | $6.9M | 11.3M | 1.3M | 433K |
| California | $160.3M | $167.3M | 45 | $3.7M | 10.5M | 437K | 233K |
| Tennessee | $131.4M | $128.5M | 18 | $7.1M | 7.1M | 492K | 397K |
| Arkansas | $128.7M | $125.7M | 4 | $31.4M | 8.0M | 480K | 2.0M |
| Illinois | $114.1M | $113.9M | 19 | $6.0M | 9.1M | 353K | 479K |
| Virginia | $107.3M | $107.3M | 22 | $4.9M | 5.6M | 335K | 256K |
| Maryland | $82.8M | $84.4M | 13 | $6.5M | 6.0M | 215K | 461K |
| Kansas | $75.6M | $75.2M | 4 | $18.8M | 4.5M | 172K | 1.1M |
| Alabama | $71.4M | $70.2M | 11 | $6.4M | 3.4M | 243K | 307K |
| Pennsylvania | $70.5M | $71.0M | 28 | $2.5M | 4.1M | 190K | 147K |
| Georgia | $68.4M | $67.3M | 22 | $3.1M | 3.9M | 272K | 176K |
| Nevada | $64.3M | $64.2M | 7 | $9.2M | 4.7M | 224K | 675K |
| Arizona | $61.8M | $61.4M | 7 | $8.8M | 4.7M | 136K | 667K |
| Colorado | $53.4M | $53.6M | 6 | $8.9M | 2.7M | 151K | 445K |
| South Carolina | $51.0M | $50.7M | 8 | $6.3M | 3.9M | 127K | 490K |
| Ohio | $48.8M | $48.3M | 16 | $3.0M | 3.3M | 162K | 205K |
| North Carolina | $43.6M | $43.0M | 20 | $2.2M | 2.8M | 181K | 141K |
| New Jersey | $42.3M | $44.6M | 19 | $2.3M | 3.6M | 138K | 188K |
| Mississippi | $39.3M | $38.2M | 6 | $6.4M | 2.0M | 80,677 | 326K |
| Oregon | $26.1M | $26.3M | 9 | $2.9M | 2.1M | 96,638 | 238K |
| Indiana | $26.1M | $25.7M | 9 | $2.9M | 1.8M | 88,736 | 200K |
| Nebraska | $20.7M | $20.5M | 6 | $3.4M | 1.3M | 40,851 | 216K |
| Washington | $19.8M | $19.9M | 11 | $1.8M | 1.6M | 70,531 | 143K |
| Delaware | $15.8M | $15.9M | 2 | $7.9M | 569K | 17,533 | 284K |
| Missouri | $12.3M | $12.2M | 15 | $811K | 474K | 68,723 | 31,596 |
| Louisiana | $11.9M | $11.4M | 7 | $1.6M | 582K | 37,243 | 83,077 |
| Alaska | $11.4M | $11.8M | 3 | $3.9M | 464K | 15,276 | 155K |
| Michigan | $11.2M | $11.1M | 13 | $853K | 784K | 55,770 | 60,344 |
| Maine | $10.1M | $10.1M | 2 | $5.1M | 746K | 27,958 | 373K |
| New Mexico | $8.9M | $8.8M | 5 | $1.8M | 512K | 50,698 | 102K |
| Connecticut | $6.0M | $6.3M | 7 | $900K | 732K | 26,028 | 105K |
| Massachusetts | $5.0M | $5.1M | 10 | $510K | 333K | 18,105 | 33,255 |
| Kentucky | $4.8M | $4.9M | 6 | $812K | 155K | 30,664 | 25,861 |
| Minnesota | $4.4M | $4.4M | 5 | $873K | 300K | 6,352 | 60,000 |
| Iowa | $4.4M | $4.3M | 2 | $2.2M | 256K | 8,372 | 128K |
| Rhode Island | $2.0M | $2.1M | 2 | $1.0M | 30,577 | 18,395 | 15,288 |
| Wisconsin | $1.9M | $1.9M | 5 | $372K | 154K | 24,508 | 30,754 |
| Hawaii | $1.8M | $1.9M | 2 | $951K | 85,093 | 11,143 | 42,546 |
| South Dakota | $1.6M | $1.6M | 2 | $800K | 83,791 | 1,864 | 41,896 |
| PR | $1.5M | $1.4M | 7 | $205K | 65,557 | 5,212 | 9,365 |
| Oklahoma | $945K | $880K | 5 | $176K | 13,564 | 7,209 | 2,713 |
| New Hampshire | $770K | $806K | 3 | $269K | 164K | 2,088 | 54,546 |
| District of Columbia | $118K | $128K | 3 | $43K | 1,736 | 680 | 579 |
| VI | $100K | $99K | 1 | $99K | 1,450 | 559 | 1,450 |
| Vermont | $66K | $63K | 1 | $63K | 794 | 402 | 794 |
| North Dakota | $64K | $61K | 1 | $61K | 884 | 488 | 884 |
| West Virginia | $39K | $42K | 3 | $14K | 522 | 407 | 174 |
| Utah | $36K | $35K | 1 | $35K | 1,017 | 342 | 1,017 |
| Montana | $21K | $22K | 1 | $22K | 213 | 124 | 213 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
5 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J9271 · Injection, pembrolizumab, 1 mg | $712.9M | 16.1M | FLTXNYCATN |
| J0897 · Injection, denosumab, 1 mg | $179.5M | 8.8M | FLTXNYCATN |
| J9144 · Injection, daratumumab, 10 mg and hyaluronidase-fihj | $171.9M | 4.4M | FLTXNYCATN |
| J9299 · Injection, nivolumab, 1 mg | $113.0M | 4.6M | FLTXNYCATN |
| G6015 · Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | $53.1M | 195K | FLTXNYCATN |
| J0881 · Injection, darbepoetin alfa, 1 microgram (non-esrd use) top by services | $29.1M | 12.6M | FLTXNYCATN |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | $18.0M | 20.7M | FLTXNYCATN |
| J0185 · Injection, aprepitant, 1 mg top by services | $6.5M | 4.9M | FLTXNYCATN |
| Q0138 · Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) top by services | $4.3M | 15.9M | FLTXNYCATN |
| J1756 · Injection, iron sucrose, 1 mg top by services | $1.0M | 6.0M | FLTXNYCATN |
| J1453 · Injection, fosaprepitant, 1 mg top by services | $684K | 6.2M | FLTXNYCATN |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $590K | 5.8M | FLTXNYCATN |